King International Investment Ltd
00928
Company Profile
Business description
King International Investment Ltd is an investment holding company. The company's operating segment includes the Healthcare products and services business, Money lending business and sales of liquor business. It generates maximum revenue from the sales of liquor business segment. Geographically, it derives a majority of revenue from PRC. The group is a provider of genetic testing and health data analysis services.
Contact
No. 338 King’s Road
Suite 2001, 20th floor
Two Chinachem Exchange Square
North Point
Hong Kong
HKGSector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
31 March 2026
Employees
13
Stocks News & Analysis
stocks
Strong result for ASX insurer but not the new norm
Stellar first half profits but increasing competition will lower future rate increases.
stocks
Eli Lilly earnings: Weak Orforglipron obesity data weighs down a strong quarter
With today’s share drop, we think Lilly stock looks fairly valued.
stocks
Solid 2025 for A-REIT but development activity will weigh on 2026
Positive news for income investors as yield exceeds 5%.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,104.30 | 27.70 | 0.31% |
| CAC 40 | 7,743.00 | 33.68 | 0.44% |
| DAX 40 | 24,162.86 | 29.64 | -0.12% |
| Dow JONES (US) | 44,175.61 | 206.97 | 0.47% |
| FTSE 100 | 9,095.73 | 5.04 | -0.06% |
| HKSE | 24,844.12 | 14.70 | -0.06% |
| NASDAQ | 21,450.02 | 207.32 | 0.98% |
| Nikkei 225 | 41,820.48 | 761.33 | 1.85% |
| NZX 50 Index | 12,906.21 | 61.58 | 0.48% |
| S&P 500 | 6,389.45 | 49.45 | 0.78% |
| S&P/ASX 200 | 8,833.60 | 26.50 | 0.30% |
| SSE Composite Index | 3,641.91 | 6.78 | 0.19% |